MAPT and Alzheimer disease: Mutations in other genes such as Apolipoprotein E (APOE) and tau (MAPT) are associated with increased risk of sporadic, late onset AD though they not on their own sufficient to cause the disease (Coon et al., 2007; Allen et al., 2014).